Regulation (EU) No 528/2012 on Biocidal Products (retained in UK law as GB BPR via European Union (Withdrawal) Act 2018)
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (Text with EEA relevance)
Regulations creating concrete business duties or carrying penalties, grouped as the instrument is structured. Titles link to the source text — blue means you’re leaving for legislation.gov.uk.
s.art010
Active substances which are candidates for substitution
RegulatedOther duties (1) — Crown / regulator
HSE must assess candidate-for-substitution criteria and consult on potential candidatesStatutory regulator
s.art020
Requirements for applications for authorisation
Regulated
Submit required documents with biocidal product authorisation applicationApplicant
s.art058
Placing on the market of treated articles
Regulated
Ensure treated articles meet GB BPR labelling and substance approval rulesAny Person
s.art065
Compliance with requirements
Regulated
Maintain production records and batch samples for biocidal productsManufacturer
s.art068
Record-keeping and reporting
Regulated
Keep records of biocidal products for 10 years and share with HSE on requestManufacturer
s.art069
Classification, packaging and labelling of biocidal products
Regulated
Classify, package and label biocidal products according to approved product characteristicsManufacturer
113 other provisions — procedural and definitional
s.annex iv para.1
This Annex sets out rules to be followed when the...
s.annex iv para.2
The reasons for such adaptations to the data requirements must...
s.art001
Purpose and subject matter
s.art002
Scope
s.art003
Definitions
s.art004
Conditions for approval
s.art005
Exclusion criteria
s.art006
Data requirements for an application
s.art007
Submission and validation of applications
s.art008
Evaluation of applications
s.art008
The GB List
s.art009
Approval of an active substance
s.art011
Technical guidance notes
s.art012
Conditions for renewal
s.art013
Submission and acceptance of applications
s.art014
Evaluation of applications for renewal
s.art015
Review of approval of an active substance
s.art016
Implementing measures
s.art017
Making available on the market and use of biocidal products
s.art017
NI Product Market Access
s.art018
Measures geared to the sustainable use of biocidal products
s.art019
Conditions for granting an authorisation
s.art021
Waiving of data requirements
s.art022
Content of authorisation
s.art023
Comparative assessment of biocidal products
s.art024
Technical guidance notes
s.art024
The Simplified Active Substance List
s.art025
Eligibility for the simplified authorisation procedure
s.art026
Applicable procedure
s.art027
Making available on the market of biocidal products authorised in accordance with the simplified authorisation procedure
s.art028
Amendment of the Simplified Active Substance List
s.art029
Submission and validation of applications
s.art030
Evaluation of applications
s.art031
Renewal of a national authorisation
s.art032
Authorisation through mutual recognition
s.art033
Mutual recognition in sequence
s.art034
Mutual recognition in parallel
s.art035
Referral of objections to the coordination group
s.art036
Referral of unresolved objections to the Commission
s.art037
Derogations from mutual recognition
s.art038
Opinion of the Agency
s.art039
Application for mutual recognition by official or scientific bodies
s.art040
Supplementary rules and technical guidance notes
s.art041
Union authorisation
s.art042
Biocidal products for which Union authorisation may be granted
s.art043
Submission and validation of applications
s.art044
Evaluation of applications
s.art045
Submission and acceptance of applications
s.art046
Evaluation of applications for renewal
s.art047
Obligation for notification of unexpected or adverse effects
s.art048
Cancellation or amendment of an authorisation
s.art049
Cancellation of an authorisation at the request of the authorisation holder
s.art050
Amendment of an authorisation at the request of the authorisation holder
s.art051
Detailed rules
s.art052
Period of grace
s.art053
Parallel trade
s.art054
Assessment of technical equivalence
s.art055
Derogation from the requirements
s.art056
Research and development
s.art057
Exemption from registration under Regulation (EC) No 1907/2006
s.art059
Protection of data held by the competent authority
s.art060
Data protection periods
s.art061
Letter of access
s.art062
Data sharing
s.art063
Compensation for data sharing
s.art064
Use of data for subsequent applications
s.art066
Confidentiality
s.art067
Electronic public access
s.art070
Safety data sheets
s.art071
Exchange of information
s.art072
Advertising
s.art073
Poison control
s.art074
Role of the Agency
s.art075
Biocidal Products Committee
s.art076
Secretariat of the Agency
s.art077
Appeals
s.art078
The budget of the Agency
s.art079
Formats for submission of information to the competent authority
s.art080
Fees and charges
s.art081
The competent authority
s.art082
Committee procedure
s.art083
Exercise of the delegation
s.art083
Regulation procedure
s.art083
The consent requirement
s.art084
Urgency procedure
s.art085
Adaptation to scientific and technical progress
s.art086
Active substances included in Annex I to Directive 98/8/EC
s.art087
Penalties
s.art088
Safeguard clause
s.art089
Existing transitional measures
s.art090
Transitional measures concerning active substances evaluated under Directive 98/8/EC
s.art091
Transitional measures concerning applications for biocidal product authorisations submitted under Directive 98/8/EC
s.art092
Transitional measures concerning biocidal products authorised/registered under Directive 98/8/EC
s.art093
Transitional measures concerning biocidal products not covered by the scope of Directive 98/8/EC
s.art095
Transitional measures for applications for same biocidal product authorisations
s.art095
Transitional measures for applications for same biocidal product authorisations under the simplified procedure
s.art095
Transitional measures for Regulation (EU) No 528/2012 authorisations
s.art095
Transitional measures for ongoing applications for Union authorisations
s.art095
Transitional measures for Article 95 List
s.art095
Transitional measure for active substance applications made to the United Kingdom competent authority before 30 March 2019 and subsequently reallocated
s.art095
Transitional measure for active substance applications made before IP completion day pursuant to Article 93 where the United Kingdom competent authority was not the evaluating competent authority
s.art095
Transitional measures for renewal of an approval of an active substance
s.art095
Transitional measures for ongoing applications to change or amend authorisations
s.art095
Interpretation of Articles 95A to 95M
s.art096
Repeal
s.art097
Entry into force
Help complying
Guvnor’s practical routes through this instrument.